Skip to main content
OpenTrials
Completed

NCT Number: NCT05087420

Migraine in Poland - a Web-based Cross-sectional Survey

A survey of Polish respondents will aim to define migraine characteristics in Polish subjects. To achieve this, a structured questionnaire based mainly on American Migraine Prevalence and Prevention Study has been prepared to serve as a tool for data extraction. The obtained data should allow for defining disease parameters, burden and received treatments. Additionally questions regarding patients rhinological symptoms and COVID-19-related history were included.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Migraine Brain Diseases COVID-19 Central Nervous System Diseases Coronaviridae Infections Coronavirus Infections Headache Headache Disorders Headache Disorders, Primary Infections Lung Diseases Migraine Disorders Nervous System Diseases Neurologic Manifestations Nidovirales Infections Nose Diseases Otorhinolaryngologic Diseases Pain Paranasal Sinus Diseases Pathological Conditions, Signs and Symptoms Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Rhinitis Rhinosinusitis Signs and Symptoms Sinusitis Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Marcin Straburzyński, Dźwierzuty, Warmian-Masurian Voivodeship, Poland

Loading trial locations.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • consent to participate in the study

Exclusion criteria

  • responses missing in questionnaire

Treatment and study plan

Primary outcomes

  1. Headache phenotype

    Time frame: in the preceding year

    Classification of reported headache according to International Classification of Headache Disorders

  2. Migraine burden

    Time frame: in the preceding year

    Consequences of the disease measured by the Migraine Disability Assessment Test

Secondary outcomes

  1. Monthly headache days

    Time frame: in the preceding month

    Number of days per month

  2. Monthly headache days

    Time frame: in the preceding year

    Number of days per year

  3. Time from last headache professional consultation

    Time frame: in the preceding 10 years

    Number of months

  4. Migraine diagnosed by headache professional

    Time frame: in the preceding 10 years

    yes/no

  5. Age at diagnosis

    Time frame: from the onset of headache (time frame up to 99 years)

    years

  6. Comoribidities

    Time frame: in the preceding year

    Disease according to International Classsification of Disease 10

  7. Type of previous headache professional consultation

    Time frame: in the preceding 10 years

    Name of headache profession/speciality

  8. Number of consultations in the last year

    Time frame: in the last 12 months

    Number 0-100

  9. Number of consultations in the last year because of headaches

    Time frame: in the last 12 months

    Number 0-100

  10. Number of days spent in hospital in the last year because of headaches

    Time frame: in the last 12 months

    Number 0-100

  11. Acute treatment used

    Time frame: in the preceding 10 years

    Name of abortive medication

  12. Preventive treatment used

    Time frame: in the preceding 10 years

    Name of abortive medication

  13. Acute treatment frequency

    Time frame: in the last 3 months

    Number of days per month

  14. Preventive treatment frequency

    Time frame: in the last 12 months

    Number of months form the last dose

  15. Preventive treatment effectiveness

    Time frame: in the last 12 months

    Likert scale

  16. Employment

    Time frame: in the last 12 months

    Type of employment

  17. Time spent at work

    Time frame: in the last 12 months

    Number of hours per week

  18. Work absence due to headache

    Time frame: in the last month

    Number of days per month

  19. Presenteeism

    Time frame: in the last month

    Number of days per month

  20. PHQ-9 Patient Health Questionnaire

    Time frame: in the last 2 weeks

    Number

  21. Sinus headache

    Time frame: in the last 3 months

    Number of days

  22. Sinonasal symptoms accompanying headache

    Time frame: in the last 12 months

    Type of symptoms

  23. Sinonasal symptoms not associated with headache

    Time frame: in the last 12 months

    Type of symptom

  24. COVID-19 association with headache

    Time frame: in the last 2 years

    Likert scale

  25. COVID-19 vaccine association with headache

    Time frame: in the last year

    Likert scale

Sponsors and collaborators

Lead sponsor

Swiat Zdrowia

Other

Collaborators

  • Wroclaw Medical University

Registry information

Acronym: MIGinPOL2021

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Oct 21, 2021
Registry last updated
May 4, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.